Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To present nationally representative data on the lifetime prevalence and comorbidity of 8 specific drug use disorders, separately for abuse and dependence, and mood and anxiety disorders. METHOD: Data come from a representative sample (N=43,093) of the United States civilian, noninstitutional population 18 years and older. Diagnoses of mood, anxiety, and drug use disorders were based upon face-to-face personal interviews using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version (AUDADIS-IV). RESULTS: Associations between specific mood and anxiety disorders and specific drug use disorders were virtually all positive and statistically significant (p<.05). In general, associations were greater for dependence than abuse, greater for mood than anxiety disorders, and in some instances stronger among women than men (p<.05). Large odds ratios also were observed for individuals with comorbid mood and anxiety disorders. CONCLUSION: The comorbidity between specific mood and anxiety disorders and specific drug use disorders is pervasive in the U.S. population. Findings suggest that comorbid psychiatric disorders may increase the risk of greater involvement in more serious illicit drug use disorders and that the greater comorbidity between mood and anxiety and drug use disorders among women may reflect greater deviance and psychopathology among drug-using women than men. Findings also suggest that drug abuse prevention and intervention efforts should address other psychiatric conditions. Further, definitions of drug use disorder phenotypes should give careful consideration to other psychiatric conditions as meaningful characteristics of case heterogeneity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anxiety disorders are highly comorbid with substance use disorders [43]”
From Correlates of Quality of Life in Anxiety Disorders: Review of Recent Research (2021) · cites this paper as [43]
In the citing paper
“relapse for SUD, experience increased distress, internalized stigma, lower quality of life, and a higher likelihood of using multiple substances than people diagnosed with SUD alone(Carpentier et al., 2009; Chang et al., 2019; Conway et al., 2006; Lejuez et al., 2008; Rogers et al., 2019).”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Conway et al., 2006
In the citing paper
“GAD, PD, agoraphobia, social phobia, and specific phobias are often found to be highly co-morbid with each other as well as other psychiatric disorders including depression, PTSD, and substance-use disorders (Conway et al, 2006;Kaufman and Charney, 2000;Regier et al, 1998).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Conway et al, 2006
In the citing paper
“Furthermore, gambling disorder frequently co-occurs with substance use disorders, particularly alcohol and nicotine, as well as mood and anxiety disorders (Conway, Compton, Stinson, & Grant, 2006; B. F. Grant et al., 2004b; Petry et al., 2005; Ronzitti, Kraus, Hoff, & Potenza, 2018).”
From Cued for Risk: Evidence for an Incentive Sensitization Framework to Explain the Interplay between Stress and Anxiety, Substance Abuse, and Reward Uncertainty in Disordered Gambling Behavior (2019) · cites this paper as Conway, Compton, Stinson, & Grant, 2006
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Kessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996) · American Journal of Orthopsychiatry · doi:10.1037/h0080151 · Cited by 1,378
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, P. S., Kay, W., & Pickering, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00070-x · Cited by 1,110
Self-citationHelzer, J. E., & Pryzbeck, T. R. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.219 · Cited by 1,081
Comorbidity of substance use disorders with mood and anxiety disorders
Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S., Bijl, R., Borges, G., Caraveo-Anduaga, J. J., Dewit, D. J., et al. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00076-8 · Cited by 725
Grant, B. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01134-k · Cited by 686
Self-citationGrant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.361 · Cited by 644
Self-citation
Cited by
Items 101–200 of 933
Concurrent Disorder Management Guidelines. Systematic Review
Hakobyan, S., Vazirian, S., Lee-Cheong, S., Krausz, M., Honer, W. G., & Schutz, C. G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082406 · Cited by 99
“In population-based studies, approximately one-fourth of people with anxiety or major depressive disorders are expected to have an overlapping substance use disorder in their lifetime [6,7].”
BackgroundDuchesne, S., & Ratelle, C. F. (2013) · Journal of Youth and Adolescence · doi:10.1007/s10964-013-0029-z · Cited by 129
“This high incidence of depressive symptomatology can be especially debilitating because it increases the risk for clinical disorders, substance abuse, and suicide, and can contribute to the deterioration of social relationships, cognitive functioning, and academic performance (Avenevoli et al. 2008; Conway et al. 2006…”
BackgroundPsychiatric comorbidity and the persistence of drug use disorders in the United States
Fenton, M. C., Keyes, K., Geier, T., Greenstein, E., Skodol, A., Krueger, B., Grant, B. F., & Hasin, D. S. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03638.x · Cited by 99
“Given that mood and anxiety disorders commonly co-occur (55), we created three combined categories to avoid collinearity: unipolar affective (major depression, dysthymia); bipolar (bipolar I, bipolar II); and anxiety (panic, social anxiety, specific phobia, generalized anxiety).”
BackgroundSelf-citationSamet, S., Fenton, M. C., Nunes, E., Greenstein, E., Aharonovich, E., & Hasin, D. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04010.x · Cited by 98
van der Pol, P., Liebregts, N., de Graaf, R., ten Have, M., Korf, D. J., van den Brink, W., & van Laar, M. (2013) · Addiction · doi:10.1111/add.12196 · Cited by 107
“However, in most studies the overlap (an estimated 20–50% [8,9]) between dependent users and frequent users is ignored [1–5,10–16].”
Kerridge, B. T., Chou, S. P., Pickering, R. P., Ruan, W. J., Huang, B., Jung, J., Zhang, H., Fan, A. Z., Saha, T. D., Grant, B. F., et al. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.11.005 · Cited by 95
Self-citationNikolova, Y. S., Knodt, A. R., Radtke, S. R., & Hariri, A. R. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.85 · Cited by 94
Acamprosate for Alcohol Dependence: A Sex‐Specific Meta‐Analysis Based on Individual Patient Data
Mason, B. J., & Lehert, P. (2012) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01616.x · Cited by 94
Alloy, L. B., Bender, R. E., Wagner, C. A., Whitehouse, W. G., Abramson, L. Y., Hogan, M. E., Sylvia, L. G., & Harmon‐Jones, E. (2009) · Journal of Personality and Social Psychology · doi:10.1037/a0016061 · Cited by 105
“Consistent with prior evidence of high co-occurrence between bipolar disorders and SUDs (e.g., Conway et al., 2006; Grant et al., 2004), our initial analyses revealed that individuals with bipolar spectrum disorders were at elevated risk for lifetime SUDs and that they exhibited higher levels of…”
InfluentialMartins, S. S., & Gorelick, D. A. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.05.010 · Cited by 94
“The strength of associations between psychiatric disorders and CA+ CD in the present study somewhat resembles that found in other studies of lifetime substance use disorders (Compton et al., 2007; Conway et al., 2006; Conway et al., 2007).”
BackgroundResultHIV and adolescents: focus on young key populations
Bekker, L., & Hosek, S. (2015) · Journal of the International AIDS Society · doi:10.7448/ias.18.2.20076 · Cited by 113
Fatseas, M., Serre, F., Swendsen, J., & Auriacombe, M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.03.008 · Cited by 89
Roos, C. R., Bowen, S., & Witkiewitz, K. (2017) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000249 · Cited by 92
“Considering the high rates of comorbidity of SUD with depression and anxiety (Conway, Compton, Stinson, & Grant, 2006; Grant, 1995), and the poor treatment outcomes common in comorbid clients (Dodge, Sindelar, & Sinha, 2005; Hasin et al., 2002; McKay et al., 2016; Simpson, Joe, & Broome, 2004)…”
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92
“Moreover, the prevalent comorbidity between affective disorders and substance use disorders has led to the suggestion that affective dysregulation is an antecedent to addiction (Bruijnzeel et al., 2004; Castle, 2008; Conway et al., 2006; Pani et al., 2010; Schuckit, 2006), providing further impetus for understanding t…”
BackgroundMetrik, J., Jackson, K. M., Bassett, S. S., Zvolensky, M. J., Seal, K. H., & Borsari, B. E. (2016) · Psychology of Addictive Behaviors · doi:10.1037/adb0000210 · Cited by 103
“Nevertheless, similar to the temporal relation between PTSD and CUD (e.g., Hien et al., 2010), MDD is typically found to precede CUD and contribute to its etiology (Agosti et al., 2002; Conway et al., 2006).”
BackgroundThe 21st century psychedelic renaissance: heroic steps forward on the back of an elephant
Sessa, B. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4713-7 · Cited by 106
White-matter abnormalities in brain during early abstinence from methamphetamine abuse
Tobias, M. C., O’Neill, J., Hudkins, M., Bartzokis, G., Dean, A. C., & London, E. D. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1761-7 · Cited by 91
Farris, S. G., Metrik, J., Bonn-Miller, M. O., Kahler, C. W., & Zvolensky, M. J. (2016) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2016.77.889 · Cited by 90
“IT IS ESTIMATED THAT 43%–48% of individuals with cannabis use disorders also have a comorbid anxiety or mood disorder (e.g., Buckner et al., 2012; Conway et al., 2006; Cougle et al., 2011; Stinson et al., 2006; Tournier et al., 2003).”
Management of comorbid bipolar disorder and substance use disorders
Salloum, I. M., & Brown, E. S. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1292279 · Cited by 91
Pharmacological treatments for methamphetamine addiction: current status and future directions
Ballester, J., Valentine, G., & Sofuoglu, M. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1268916 · Cited by 89
“National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) data has shown that among individuals who use MA, the lifetime prevalence of mood and anxiety disorders was 51% and 39%, respectively [29].”
BackgroundClinical classification in mental health at the cross-roads: which direction next?
Hickie, I. B., Scott, J., Hermens, D. F., Scott, E. M., Naismith, S. L., Guastella, A. J., Glozier, N., & McGorry, P. D. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-125 · Cited by 90
“Avoid the use of single categorical states (for example, major depression, schizophrenia, bipolar disorder) that describe heterogeneous groups Only use major depression in association with specific descriptors including early- versus late-onset, preceded by childhood anxiety; comorbid with alcohol or other substance m…”
BackgroundGoldstein, R. B., Compton, W. M., Pulay, A. J., Ruan, W. J., Pickering, R. P., Stinson, F. S., & Grant, B. F. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.02.023 · Cited by 98
Self-citationRosic, T., Naji, L., Bawor, M., Dennis, B. B., Plater, C., Marsh, D. C., Thabane, L., & Samaan, Z. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s129480 · Cited by 96
“16–18 Similarly, patients with OUD have a higher lifetime prevalence of psychiatric disorders, including other substance use disorders (SUDs), compared to that in the general population.”
BackgroundAndreas, J. B., Lauritzen, G., & Nordfjærn, T. (2015) · Addictive Behaviors · doi:10.1016/j.addbeh.2015.05.001 · Cited by 108
Soyka, M., Kranzler, H. R., Hesselbrock, V., Kasper, S., Mutschler, J., Möller, H.-J., & The WFSBP Task Force on Treatment Guidelines for Substance Use Disorders (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1246752 · Cited by 85
“There is a lifetime prevalence of 6–20% for anxiety disorders among alcohol-dependent individuals, with social and specific phobias having the highest risk (Kessler et al. 1997; Grant et al. 2005; Conway et al. 2006).”
BackgroundGlasner‐Edwards, S., Mooney, L. J., Marinelli‐Casey, P., Hillhouse, M., Ang, A., Rawson, R., & Methamphetamine Treatment Project Corporate Authors (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00061.x · Cited by 86
A placebo-controlled trial of buspirone for the treatment of marijuana dependence
McRae-Clark, A. L., Carter, R. E., Killeen, T. K., Carpenter, M. J., Wahlquist, A. E., Simpson, S. A., & Brady, K. T. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.06.022 · Cited by 87
“Another study documented a 28.8% lifetime prevalence of anxiety disorders among those with marijuana use disorders (Conway et al., 2006).”
BackgroundInfluentialNeuropsychiatric Adverse Effects of Amphetamine and Methamphetamine
Harro, J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.02.004 · Cited by 105
Prisciandaro, J. J., Joseph, J. E., Myrick, H., McRae-Clark, A. L., Henderson, S., Pfeifer, J., & Brady, K. T. (2014) · Addiction · doi:10.1111/add.12666 · Cited by 82
“These numbers are especially concerning because cocaine use is consistently associated with substantially increased mortality (2), psychiatric illness (3), functional impairment (4), and criminal behavior (5).”
BackgroundLazareck, S., Robinson, J. A., Crum, R. M., Mojtabai, R., Sareen, J., & Bolton, J. M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07345 · Cited by 82
Peters, R. H., Young, M. S., Rojas, E. C., & Gorey, C. M. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1303838 · Cited by 96
Soyka, M., Kranzler, H. R., Berglund, M., Gorelick, D., Hesselbrock, V., Johnson, B. A., Möller, H.-J., THE WFSBP TASK FORCE ON TREATMENT G, Soyka, M., Kranzler, H. R., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970801896390 · Cited by 80
“Social and specific phobias have the highest risk (Kessler et al. 1997; Grant et al. 2005; Conway et al. 2006).”
BackgroundModelling mood disorders: An ACE solution?
Malhi, G. S., Irwin, L., Hamilton, A., Morris, G., Boyce, P., Mulder, R., & Porter, R. J. (2018) · Bipolar Disorders · doi:10.1111/bdi.12700 · Cited by 79
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
Zlebnik, N. E., & Cheer, J. F. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014038 · Cited by 77
“Comorbidity among these disorders is highly prevalent, with as many as 30–40% of individuals suffering from drug addiction also meeting criteria for depression or an anxiety disorder (Conway et al. 2006).”
Fergusson, D. M., Boden, J. M., & Horwood, L. J. (2011) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0268-1 · Cited by 78
“internalizing disorders, including major depression and anxiety disorders, have been well documented [1-5].”
BackgroundResultOstacher, M. J. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.12.009 · Cited by 79
LYNSKEY, M. T., & AGRAWAL, A. (2007) · Psychological Medicine · doi:10.1017/s0033291707000396 · Cited by 76
“Consistent with the existing literature (Regier et al. 1990; Merikangas et al. 1998; Sakai et al. 2004; Conway et al. 2006; Rodriguez-Llhera et al. 2006), individuals meeting criteria for illicit drug dependence had the highest mean rates of psychiatric disorders.”
Flórez-Salamanca, L., Secades-Villa, R., Hasin, D. S., Cottler, L., Wang, S., Grant, B. F., & Blanco, C. (2013) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.772618 · Cited by 76
Self-citationPhillips, A. E., Faghih, M., Drewes, A. M., Singh, V. K., Yadav, D. K., & Olesen, S. S. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000782 · Cited by 81
Bipolar Disorder and Comorbid Use of Illicit Substances
Preuss, U. W., Schaefer, M., Born, C., & Grunze, H. (2021) · Medicina · doi:10.3390/medicina57111256 · Cited by 132
“The rate of comorbid alcohol and substance-related disorders (AUD and SUD) in BD is, as expected, disproportionately high [9] and accomplish up to 50% for bipolar I disorder [10].”
BackgroundTull, M. T., Gratz, K. L., Aklin, W. M., & Lejuez, C. W. (2010) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2009.08.006 · Cited by 75
“…covariates, participants were administered a demographic form, and given the high rates of depression among individuals with PTSD and/or SUDs (Conway et al., 2006; Grant et al., 2004; Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995), participants were also administered the Center…”
Fischer, B., Blanken, P., da Silveira, D. X., Gallassi, A. D., Goldner, E. M., Rehm, J. T., TYNDALL, M. W., & Wood, E. (2015) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2015.01.002 · Cited by 101
Cognitive Vulnerability to Depression in Canadian and Chinese Adolescents
Auerbach, R. P., Eberhart, N. K., & Abela, J. R. Z. (2009) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-009-9344-y · Cited by 82
“Subclinical levels of depressive symptoms are also associated with a number of poor outcomes in adulthood such as increased stressful life events, lower income levels, poorer social support, greater marital conflict, and higher incidence of substance use and dependence (Conway et al. 2006; Franko et al. 2005; Gotlib e…”
BackgroundComorbid Bipolar and Alcohol Use Disorder—A Therapeutic Challenge
Grunze, H., Schaefer, M., Scherk, H., Born, C., & Preuss, U. W. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.660432 · Cited by 106
Schuler, M. S., Vasilenko, S. A., & Lanza, S. T. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.10.005 · Cited by 85
“Furthermore, despite notable gender differences in the prevalence of alcohol and substance use disorders, which are more common among men (Conway et al., 2006), and depression, which is more common among women (Hasin et al., 2005), few studies have examined gender differences in the associations…”
BackgroundSubstance abuse in the United States: Findings from recent epidemiologic studies
Schulden, J. D., Thomas, Y. F., & Compton, W. M. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0053-6 · Cited by 87
Self-citationToward an Improved Model of Treating Co-Occurring PTSD and Substance Use Disorders
Back, S. E. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09111602 · Cited by 72
“Over the last 20 years, evidence of the frequent co-occurrence of substance use disorders and other psychiatric disorders and the negative impact of comorbidity on treatment outcomes has increased (3).”
BackgroundBiselli, T., Lange, S. S., Sablottny, L., Steffen, J., & Walther, A. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14603 · Cited by 72
Cocaine Use Disorder (CUD): Current Clinical Perspectives
Schwartz, E. K. C., Wolkowicz, N. R., Aquino, J. P. D., MacLean, R. R., & Sofuoglu, M. (2022) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s337338 · Cited by 102
“Among responders in the US National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), 45% of cocaine users reported a lifetime mood disorder, and 31% reported a lifetime anxiety disorder.(47) Compared to those who have never used cocaine, current cocaine use is associated with an almost tripled risk for…”
BackgroundAnxiety disorders and substance use disorders: Different associations by anxiety disorder
Marmorstein, N. R. (2011) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2011.09.005 · Cited by 86
Yoon, Y.-H., Chen, C. M., Yi, H.-Y., & Moss, H. B. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.10.005 · Cited by 71
“Substance use disorders often co-occur within individuals who suffer from mood disorders [1-11].”
BackgroundCo-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity
Meier, A., Lambert-Harris, C. A., McGovern, M. P., Xie, H., An, M. L., & McLeman, B. M. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2014.910519 · Cited by 81
Treatment of Co-occurring Anxiety Disorders and Substance Use Disorders
McHugh, R. K. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000058 · Cited by 71
“Even when excluding diagnoses of PTSD and OCD, the prevalence of ADs remains high, with an estimated past-year prevalence of 11% and lifetime prevalence of 16%.(1,4) The prevalence of SUDs is approximately 9% for the past year(1,14) and over 10% and 30% lifetime for drug and alcohol use disorders, respectively.”
BackgroundInfluentialAgterberg, S., Schubert, N., Overington, L., & Corace, K. M. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.01.005 · Cited by 95
Changes in drinking days among United States adults during the COVID‐19 pandemic
Nordeck, C. D., Riehm, K. E., Smail, E. J., Holingue, C., Kane, J. C., Johnson, R. M., Veldhuis, C. B., Kalb, L. G., Stuart, E. A., Kreuter, F., et al. (2021) · Addiction · doi:10.1111/add.15622 · Cited by 75
Severity of gambling is associated with severity of depressive symptoms in pathological gamblers
Rømer Thomsen, K., Callesen, M. B., Linnet, J., Kringelbach, M. L., & Møller, A. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283305e7a · Cited by 70
“Findings from the present study emphasize the close relationship between pathological gambling and depressive symptoms – an association which has also been systematically reported in substance use disorders (Compton et al., 2000, 2007; Kessler et al., 2003; Grant et al., 2004; Conway et al., 2006).”
BackgroundLongitudinal predictors of bipolar spectrum disorders: A behavioral approach system perspective.
Alloy, L. B., Abramson, L. Y., Urosevic, S., Bender, R. E., & Wagner, C. A. (2009) · Clinical Psychology: Science and Practice · doi:10.1111/j.1468-2850.2009.01160.x · Cited by 69
Substance Use Disorders and Anxiety: A Treatment Challenge for Social Workers
Brady, K. T., Haynes, L. F., Hartwell, K. J., & Killeen, T. K. (2013) · Social Work in Public Health · doi:10.1080/19371918.2013.774675 · Cited by 68
Hellberg, S. N., Russell, T. I., & Robinson, M. J. F. (2019) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/s13415-018-00662-3 · Cited by 65
Multimorbidity Patterns in the General Population: Results from the EpiChron Cohort Study
Ioakeim‐Skoufa, I., Poblador‐Plou, B., Carmona‐Pírez, J., Díez‐Manglano, J., Navickas, R., Gimeno-Feliú, L. A., González‐Rubio, F., Jurevičienė, E., Dambrauskas, L., Prados‐Torres, A., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17124242 · Cited by 76
Gender Dynamics in Substance Use and Treatment
Harris, M. T. H., Laks, J., Stahl, N. E., Bagley, S. M., Saia, K., & Wechsberg, W. M. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.08.007 · Cited by 82
“35,36 Women are also disproportionately affected by trauma and abuse.”
BackgroundGoldstein, R. B., Dawson, D. A., Saha, T. D., Ruan, W. J., Compton, W. M., & Grant, B. F. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00364.x · Cited by 67
Self-citationPrior, K., Mills, K. L., Ross, J. E., & Teesson, M. (2016) · Drug and Alcohol Review · doi:10.1111/dar.12419 · Cited by 82
Ambrosi, E., Arciniegas, D. B., Curtis, K. N., Patriquin, M. A., Spalletta, G., Sani, G., Frueh, B. C., Fowler, J. C., Madan, A., & Salas, R. (2019) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.17120351 · Cited by 67
Hadley, S. J., Mandel, F. S., & Schweizer, E. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111405360 · Cited by 66
“Among individuals with a DSM-IV diagnosis of an anxiety disorder, tranquilizer abuse and/or dependence occurred in 10.2%, increasing to 34.4% when a comorbid depressive disorder was present (Conway et al., 2006).”
BackgroundInfluentialDepression and substance use disorders: Clinical comorbidity and shared neurobiology
Calarco, C. A., & Lobo, M. K. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.004 · Cited by 86
Booth, B. M., Curran, G. M., Han, X., Wright, P. B., Frith, S., Leukefeld, C. G., Falck, R. S., & Carlson, R. G. (2010) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2010.71.258 · Cited by 78
Zhang, M. W., Harris, K. M., & Ho, R. C. (2016) · BMC Medical Ethics · doi:10.1186/s12910-016-0087-3 · Cited by 65
“Off-label repeat prescription of ketamine may cause potential harm to depressed patients as depression and addiction are commonly comorbid [26].”
BackgroundRoberts, B., Murphy, A., Chikovani, I., Makhashvili, N., Patel, V., & McKee, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098299 · Cited by 64
“This is consistent with studies from stable settings on the association of alcohol use and common mental disorders, particularly depression [11,69,70,71].”
ResultKarpyak, V. M., Biernacka, J. M., Geske, J. R., Abulseoud, O. A., Brunner, M. D., Chauhan, M., Hall‐Flavin, D. K., Lewis, K. A., Loukianova, L. L., Melnyk, G. J., et al. (2016) · Addiction · doi:10.1111/add.13386 · Cited by 64
“indicate that female alcoholics report drinking in response to unpleasant emotions more often than males [53,54],”
BackgroundAnxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder
McHugh, R. K., Votaw, V. R., Bogunovic, O., Karakula, S. L., Griffin, M. L., & Weiss, R. D. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2016.08.020 · Cited by 64
Substance use disorders increase the odds of subsequent mood disorders
Kenneson, A., Funderburk, J. S., & Maisto, S. A. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.06.011 · Cited by 76
Liver abnormalities in drug and substance abusers
Pateria, P., de Boer, B., & MacQuillan, G. C. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.08.001 · Cited by 69
“A population based study in the United States, found high prevalence of cannabis use in patients with schizophrenia, mania, panic disorder and major depression [65].”
BackgroundMagidson, J. F., Liu, S.-M., Lejuez, C. W., & Blanco, C. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.02.011 · Cited by 68
“…substance use outcomes; epidemiology Introduction Generalized anxiety disorder (GAD) and substance use disorders (SUDs) are highly comorbid (Conway et al., 2006; Grant et al., 2004; 2005; Kessler et al., 2005), and individuals with GAD-SUD comorbidity have significantly worse outcomes than…”
BackgroundSocial defeat stress and escalation of cocaine and alcohol consumption: Focus on CRF
Newman, E. L., Leonard, M. Z., Arena, D. T., de Almeida, R. M. M., & Miczek, K. A. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.09.007 · Cited by 75
“tribute to the higher rate of co-occurring mood and substance use disorders in women than in men (Conway et al., 2006) and in screening potential pharmacotherapies for sex-dependent effects.”
Amaro, H., Spear, S., Vallejo, Z., Conron, K., & Black, D. S. (2014) · Substance Use & Misuse · doi:10.3109/10826084.2013.852587 · Cited by 62
Havinga, P., Boschloo, L., Bloemen, A. J. P., Nauta, M. H., de Vries, S. O., Penninx, B. W. J. H., Schoevers, R. A., & Hartman, C. A. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m09936 · Cited by 80
Sex Differences Among Opioid-Abusing Patients With Chronic Pain in a Clinical Trial
Manubay, J. M., Davidson, J. W., Vosburg, S. K., Jones, J. D., Comer, S. D., & Sullivan, M. A. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000086 · Cited by 66
“With regard to mood, prior studies have shown that women with chronic pain typically carry greater psychiatric comorbidity than men (Conway et al., 2006).”
BackgroundResultSalom, C., Betts, K. S., Williams, G. M., Najman, J. M., & Alati, R. (2015) · Addiction · doi:10.1111/add.13058 · Cited by 66
Kyrou, I., Kollia, N., Panagiotakos, D. B., Georgousopoulou, E. N., Chrysohoou, C. A., Tsigos, C., Randeva, H. S., Yannakoulia, M., Stefanadis, C., Papageorgiou, C., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316670918 · Cited by 73
Caputo, F., Addolorato, G., Stoppo, M., Francini, S., Vignoli, T., Lorenzini, F., Del Re, A., Comaschi, C., Andreone, P., Trevisani, F., et al. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.04.008 · Cited by 61
“, 2001) and 30–50% met criteria of psychiatric co-morbidity (Conway et al., 2006; Grant et al., 2004; Kessler, 2004).”
BackgroundComorbidity of opioid-related and anxiety-related symptoms and disorders
Langdon, K. J., Dove, K., & Ramsey, S. (2019) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2018.12.020 · Cited by 53
Simmons, L. A., & Havens, J. R. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.08.016 · Cited by 60
Anxiety level and correlates in methamphetamine-dependent patients during acute withdrawal
Su, H., Zhang, J., Ren, W., Xie, Y., Tao, J., Zhang, X., & He, J. (2017) · Medicine · doi:10.1097/md.0000000000006434 · Cited by 69
“Several studies showed that 76% of subjects reported anxiety symptoms after the onset of amphetamine use and 39% of amphetamine users reported a history of anxiety disorders.([15,16]) Likewise, an Australian research demonstrated that nearly 40% of METH treatment entrants reported a history of anxiety disorders,([17])…”
BackgroundGreen, K. M., Zebrak, K. A., Robertson, J. A., Fothergill, K. E., & Ensminger, M. E. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.11.017 · Cited by 68
Psychiatric illness delays diagnosis of esophageal cancer
O’Rourke, R. W., Diggs, B. S., Spight, D. H., Robinson, J., Elder, K. A., Andrus, J., Thomas, C. R., Hunter, J., & Jobe, B. A. (2008) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2007.00790.x · Cited by 60
Wu, L.-T. T., Ghitza, U. E., Batch, B. C., Pencina, M. J., Rojas, L. F., Goldstein, B. A., Schibler, T., Dunham, A. A., Rusincovitch, S. A., & Brady, K. T. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.09.003 · Cited by 65
“The co-occurrences of SUD with mental disorders ay be influenced by multiple pathways (e.g., self-medication, ommon risk factors, diathesis-stress) (Conway et al., 2006; Green, 005; Ingram and Luxton, 2005).”
BackgroundKirkpatrick, M. G., Goldenson, N. I., Kapadia, N., Kahler, C. W., de Wit, H., Swift, R. M., McGeary, J. E., Sussman, S. Y., & Leventhal, A. M. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4091-y · Cited by 62
“…in patients with PTSD and GAD (Charney et al. 1989; Sevy et al. 1989; Southwick et al. 1999; Geracioti et al. 2008), and both of these disorders are associated with increased likelihood of cocaine and amphetamine use disorders in the general population (Conway et al. 2006; Shaffer and Eber 2002).”
Herrenkohl, T. I., Lee, J. O., Kosterman, R., & Hawkins, J. D. (2012) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2011.11.003 · Cited by 76
“Finally, in that mental health and substance use symptoms disorders often overlap, it is important that researchers examine issues of symptom comorbidity [13, 14].”
BackgroundGrella, C. E., Rodriguez, L., & Kim, T. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2014.944960 · Cited by 61
“National survey data indicates that mood and anxiety disorders are frequently comorbid with abuse or dependence on marijuana (Conway et al. 2006).”
BackgroundSubstance Use and Substance Use Disorders
Chassin, L., Colder, C. R., Hussong, A., & Sher, K. J. (2016) · Developmental Psychopathology · doi:10.1002/9781119125556.devpsy319 · Cited by 57
Treatment of patients comorbid for addiction and other psychiatric disorders
Brady, K. T., Verduin, M. L., & Tolliver, B. K. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0048-0 · Cited by 64
“The NESARC study reported that 22% of individuals with any mood disorder and 19% of individuals with any anxiety disorder had a co-occurring drug use disorder, with greater comorbidity among women than men [3].”
BackgroundGale, C., & Davidson, O. (2007) · BMJ · doi:10.1136/bmj.39133.559282.be · Cited by 56
Lecomte, T., Mueser, K. T., MacEwan, W. G., Thornton, A. E., Buchanan, T., Bouchard, V., Goldner, E. M., Brink, J., Lang, D. J., Kang, S., et al. (2013) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000059 · Cited by 65
“Depression is common in individuals with MA dependence without psychosis, with rates varying from 13% (Salo et al., 2011) to as high as 64% (Conway et al., 2006).”
BackgroundWang, K., Burton, C. L., & Pachankis, J. E. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1391011 · Cited by 71
“Despite the well-documented comorbidity between depression and substance use problems (Conway et al., 2006; Swendsen et al., 2010) and the strong evidence supporting the association between stigma and substance use among other marginalized groups (Gibbons et al.”
BackgroundDavidson, J. R. T., Feltner, D. E., & Dugar, A. (2010) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.09r00772blu · Cited by 54
Prevalence and correlates of dual diagnoses in U.S. Latinos
Vega, W. A., Canino, G., Cao, Z., & Alegria, M. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.018 · Cited by 55
Glasner, S. V., Mooney, L. J., Marinelli‐Casey, P., Hillhouse, M. P., Ang, A., Rawson, R. A., & the Methamphetamine Treatment Project Corporate Authors (2008) · American Journal on Addictions · doi:10.1080/10550490701861110 · Cited by 59
Influence of β-Endorphin on anxious behavior in mice: interaction with EtOH
Grisel, J. E., Bartels, J. L., Allen, S. A., & Turgeon, V. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1161-4 · Cited by 55
“In the clinic, alcoholism and anxiety disorders are frequently comorbid (Kushner et al. 1990; Bradizza et al. 2006; Conway et al. 2006; Fein et al. 2007; Vendruscolo et al. 2006), and a significant proportion of alcohol-dependent individuals report that alcohol is reinforcing because it reduces anxiety (Barrenha and C…”
BackgroundReligion, Spirituality, and Depression in Adolescent Psychiatric Outpatients
Dew, R. E., Daniel, S. S., Goldston, D. B., & Koenig, H. G. (2008) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e3181663002 · Cited by 55
“This is important insofar as an inverse relationship between religiousness/spirituality and teen substance use has been found repeatedly (Koenig et al., 2001; Patock-Peckham et al., 1998; Resnick et al., 1997), and because depression is commonly comorbid with substance abuse (Conway et al., 2006).”
Background
Metadata
- Authors
- Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-02-15
- Volume
- 67
- Issue
- 02
- Pages
- 247-258
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2059057223
- Cited by
- 934
- References
- 24
- Citations by year
- 2026: 25 · 2025: 42 · 2024: 44 · 2023: 35 · 2022: 56 · 2021: 56 · 2020: 83 · 2019: 38 · 2018: 51 · 2017: 55 · 2016: 53 · 2015: 63 · 2014: 55 · 2013: 56 · 2012: 45
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- psychiatric comorbidity, mood disorders, anxiety disorders, drug use disorders, substance dependence, substance abuse, lifetime prevalence, sex differences, DSM-IV, illicit drug use
- MeSH terms
- Adolescent, Adult, Alcoholism, Anxiety Disorders, Depressive Disorder, Female, Health Surveys, Humans, Male, Psychiatric Status Rating Scales, Regression Analysis, Sex Factors, United States, Comorbidity, Prevalence, Diagnosis, Dual (Psychiatry), Mood Disorders, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.